INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Advancing Parenteral Manufacturing: The Role Of The RTU Container
Presterilized vials, syringes, and cartridges reshaped aseptic fill-finish around small batches and multi-format lines. Regulatory fit, material choices, and high-speed filling will define where the technology goes next.
-
Integration Of Container Closure Integrity In Contract Manufacturing
Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.
-
Form Fill And Seal Label Applicator For Drug Packaging
Discover a solution that ensures particularly efficient and reliable vertical and horizontal form fill and seal machine labeling.
-
The Critical Role Of Integrated Handling Design
Unplanned downtime and inconsistent throughput on syringe and injectable lines often trace back to handling design. System-level thinking about transport changes where performance is decided.
-
Nebulizers: Package Integrity Testing Challenges And Solutions1/5/2026
Maintaining sterile packaging for nebulizer drugs is vital to prevent contamination. Learn how regulatory standards and advanced leak detection methods address integrity challenges in high-risk formats.
-
Achieving EU GMP Annex 1 Compliance For Contamination Control3/4/2025
Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them3/23/2026
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Autoinjectors For Autoimmune Diseases: Benefits And Considerations8/7/2025
By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.
-
Evaluating The Entire Package System Under USP 3825/18/2026
USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
PTI Inspection Systems are scientific instruments being deployed for high risk packaging applications. The environments in which these systems operate is often highly regulated with test results having a significant impact on operational decisions. The reliability and sensitivity of a CCI test method is critical to assure that correct decisions are made to maintain product quality and patient safety. If PTI’s equipment is going to test your packaging, we aim to deliver the most effective solution. Feasibility studies offer a detailed glimpse into the technological capabilities ahead of critical purchasing decisions. Feasibility studies can also act as a preliminary test method for an application. The results from feasibility or method development testing can be rolled out to the production environment for rapid validation and deployment.
-
From start to finish, NovaPure components have been designed and manufactured using Quality by Design principles to mitigate risk for the patient.
-
Ropack recognizes that the unique design of stick-pack offers multiple benefits – for pharma and natural health products as well as to consumers.
-
Advanced inspection systems ensure packaging integrity, preventing contamination. Gain insight into automated solutions that improve quality, reduce waste, and integrate easily into production lines.
-
A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.